Quote For BioMimetic Therapeutics, Inc. BMTI.O
BioMimetic Therapeutics, Inc. (BMTI.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare ·
industry: Biotechnology ·
$10.88
27 Nov 2009
-3.29%
$11.25
$10.95
49,451
$11.27
$10.80
$15.81
$6.07
1.05
153,522
News
Press Releases
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Papasan, Larry | Chairman of the Board | -- |
| Lynch, Samuel | President, Chief Executive Officer, Director | 1,631,688 |
| Bullock, Lawrence | Chief Financial Officer | 514,635 |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $237.09 |
| Shares Outstanding (Mil.) | 21.79 |
| Float (Mil.) | 16.70 |
| Dividend Information | |
|---|---|
| Yield % | -99,999.99 |
| Annual Dividend ($ USD) | 0.00 |
| Payout Ratio(TTM) % | -- |
| Financial Strength | |
|---|---|
| Quick Ratio | 6.28 |
| Current Ratio | 7.22 |
| LT Debt/Equity | 37.25 |
| Total Debt/Equity | 44.35 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | -- |
| Price/Sales(TTM) | 81.49 |
| Price/Book(TTM) | 3.52 |
| Price/Cash Flow(TTM) | -- |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $-1.76 |
| Sales(TTM) | $0.15 |
| Book Value(MRQ) | $3.09 |
| Cash Flow(TTM) | $-1.54 |
| Cash(MRQ) | $3.18 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | -50.25 |
| Return on Assets(TTM) | -32.11 |
| Return on Investment(TTM) | -35.22 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | -- |
| Operating Margin(TTM) % | -1,183.85 |
| Profit Margin(TTM) % | -1,183.04 |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
